Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference95 articles.
1. Phase I clinical study of pertuzumab, a novel her dimerization inhibitor, in patients with advanced cancer;Agus;J Clin Oncol,2005
2. A synthetic lethal therapeutic approach: Poly (ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair;Ashworth;J Clin Oncol,2008
3. Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy;Aziz;Pharmacol Ther,2012
4. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy;Baselga;J Clin Oncol,2010
5. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer;Birgisdottir;Breast Cancer Res,2006
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role and molecular mechanism of Trametes Robiniophila Murr(Huaier) in tumor therapy;Journal of Ethnopharmacology;2024-11
2. Comparative efficacy, safety, and tolerability of pharmacotherapies for acute mania in adults: a systematic review and network meta-analysis of randomized controlled trials;Molecular Psychiatry;2024-08-27
3. Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas;Life Science Alliance;2024-07-25
4. Multi-targeting derivatives of (±)-aminoglutethimide: Synthesis, anti-leishmanial, cytotoxicity against cancerous cells and molecular docking studies;Journal of Molecular Structure;2024-06
5. WITHDRAWN: Pharmacotherapies for acute mania in adults: a systematic review and network meta-analysis of randomized controlled trials (AM-SRNMA 001);Psychiatry Research;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3